Abstract: To provide a nonaqueous electrolytic capacitor element, which contains: a positive electrode containing a positive electrode active material capable of intercalating or deintercalating anions; a negative electrode containing a negative electrode active material; and a nonaqueous electrolyte, which contains a nonaqueous solvent, an electrolyte salt containing a halogen atom, and a compound having a site capable of bonding to an anion containing a halogen atom.

Abstract: The invention described herein pertains to processes and intermediates for preparing indole containing pharmaceuticals, particularly to processes and intermediates for preparing selective estrogen receptor modulators, such as bazedoxifene.

Abstract: The invention relates to anode materials suitable for use in batteries, such as lithium ion batteries and sodium ion batteries. In particular, the anode material is a reduced graphene oxide/metal sulfide composite. Methods for forming the reduced graphene oxide/metal sulfide composite are also disclosed.

Abstract: A mobile terminal and method for controlling place recognition are provided. The method includes collecting at least one of state information about a mobile terminal and user information stored in the mobile terminal, determining whether a current place of the mobile terminal is a major place that the user has previously visited at least a number of times using the collected information, determining, if it is determined that the current place of the mobile terminal is a major place, whether the current place has been registered using at least one signal received externally, and outputting a result of the determination as to whether the current place has been registered.

Abstract: One aspect of the disclosure relates to methods of treating a fibrotic condition in an individual. The methods include administering to an individual having a fibrotic condition an effective amount of a lactic dehydrogenase (LDH) inhibitor, wherein the fibrotic condition involves an internal organ or tissue, or ocular tissue, and said administering is effective to treat the fibrotic condition. Methods of administration and pharmaceutical compositions and systems for practicing such methods are also disclosed.

Abstract: The invention relates to the use of nonpassivated silicon to produce hydrogen, by hydrolysis of the nonpassivated silicon. In particular, the invention relates to a composition comprising nonpassivated silicon, a process for producing a composition comprising nonpassivated silicon, and a process for producing hydrogen by reacting the composition with water.

Abstract: Methods, systems, and apparatus transferring power between the grid and an electric vehicle are disclosed. The apparatus may include at least one vehicle communication port for interfacing with electric vehicle equipment (EVE) and a processor coupled to the at least one vehicle communication port to establish communication with the EVE, receive EVE attributes from the EVE, and transmit electric vehicle station equipment (EVSE) attributes to the EVE. Power may be transferred between the grid and the electric vehicle by maintaining EVSE attributes, establishing communication with the EVE, and transmitting the EVSE maintained attributes to the EVE.

Abstract: A method for coding data includes: representing a first data in digital form as digital information; transforming the digital information into a first Gaussian integer; determining a relationship between the first Gaussian integer and a second Gaussian integer; and deriving, based on the determined relationship, a key for converting between the first Gaussian integer and the second Gaussian integer so as to associate the first data with a second data represented by the second Gaussian integer. The present invention also provides a system and a non-transient computer readable medium for implementing the method.

Abstract: Circuits for field-programmable receiver front ends are provided. These front ends can include a field programmable common source low noise transconductance amplifier (LNTA), a field programmable common gate LNTA, first and second four-phase I/Q mixers, first, second, third, and fourth transimpedance amplifiers, an I-path complex combiner, and a Q-path complex combiner. Transconductance cells in each of the field programmable common source LNTA and field programmable common gate LNTA can be programmed to operate in one of a class-AB mode, a class-C mode, and an OFF mode.

Abstract: Systems and methods for detecting a biological analyte are provided. The biological analyte can be, for example, cortisol. Detection can be achieved without external labels/mediators. Microfluidic systems can be incorporated into the optical sensor for enhanced point-of-care applications. The sensor can be used in a variety of low-power electronics for wearable applications.

Abstract: A method of producing an electrode of a dye-sensitized solar cell includes dispersing semiconductor nanoparticles on a transparent electrically conductive substrate, dispersing semiconductor nanofibers on the semiconductor nanoparticle layer, adsorbing onto all sides of the semiconductor nanofibers a first light absorption material, thereby sensitizing the semiconductor nanofibers, wherein the light absorption material has a first light absorption bandwidth, and depositing a second light absorption material in contact with and forming respective shells on the respective semiconductor nanofibers on which the first light absorption material is adsorbed, wherein the second light absorption material has a second light absorption bandwidth complementary to the first light absorption bandwidth.

Abstract: A dispenser for a flotation device in accordance with present embodiments may include a housing comprising an aperture. The dispenser may also include a plurality of flotation devices positioned in the housing; and a base positioned in the housing and supporting the plurality of flotation devices, wherein the base is configured to move relative to the housing to move the plurality of flotation devices jointly to position at least one flotation device adjacent to the aperture to permit removal of the at least one flotation device from the housing via the aperture.

Abstract: GB1 peptidic compounds that specifically bind to a hemagglutinin target protein, and libraries that include the same, as well as methods of making and using the same, are provided. Also provided are methods and compositions for making and using the compounds. Also provided are hemagglutinin mimics and fragments and methods of using the same, including methods of screening for GB1 peptidic compounds and methods of using conjugates the mimics as influenza A vaccines. Aspects of the invention include methods of screening libraries of L-peptidic compounds for specific binding to a D-peptidic hemagglutinin target protein. Once a L-peptidic compound has been identified that specifically binds to the D-peptidic hemagglutinin target protein, the D-enantiomer of the selected L-peptidic compound may be produced. In some embodiments, the D-enantiomer of the selected L-peptidic compound binds to, and in some instances, neutralizes influenza virus particles.

Abstract: A triptycene-based monomer, a method of making a triptycene-based monomer, a triptycene-based aromatic polyimide, a method of making a triptycene-based aromatic polyimide, methods of using triptycene-based aromatic polyimides, structures incorporating triptycene-based aromatic polyimides, and methods of gas separation are provided. Embodiments of the triptycene-based monomers and triptycene-based aromatic polyimides have high permeabilities and excellent selectivities. Embodiments of the triptycene-based aromatic polyimides have one or more of the following characteristics: intrinsic microporosity, good thermal stability, and enhanced solubility. In an exemplary embodiment, the triptycene-based aromatic polyimides are microporous and have a high BET surface area. In an exemplary embodiment, the triptycene-based aromatic polyimides can be used to form a gas separation membrane.

Abstract: A microstructure detector and in-situ method for real-time determination of the microstructure of a material undergoing alloying or other phase transformation. The method carried out by the detector includes the steps of: (a) detecting light emitted from a plasma plume created during phase transformation of a material; (b) determining at least some of the spectral content of the detected light; and (c) determining an expected microstructure of the transformed material from the determined spectral content. Closed loop control of the phase transformation process can be carried out using feedback from the detector to achieve a desired microstructure.

Abstract: An electroplating method that includes: a) contacting a first substrate with a first article, which includes a substrate and a conformable mask disposed in a pattern on the substrate; b) electroplating a first metal from a source of metal ions onto the first substrate in a first pattern, the first pattern corresponding to the complement of the conformable mask pattern; and c) removing the first article from the first substrate, is disclosed. Electroplating articles and electroplating apparatus are also disclosed.

Abstract: A method of photooxygenating furfural in a photooxygenating system, whereby a liquid mixture comprising furfural, a photosensitizer, and a reaction solvent is passed through a reaction section of the photooxygenating system, wherein the liquid mixture is exposed to solar radiation, while a portion of the furfural is oxidized in presence of the photosensitizer and a furanone compound is produced. Various embodiments of the photocatalytic water splitting reactor, and the water splitting system are also provided.

Abstract: An implantable medical device including at least one double-walled microsphere containing an active agent, and a biodegradable polymer layer containing the at least one double-walled microsphere.

Abstract: An aircraft expendable instrument, an apparatus for launching an aircraft expendable instrument, and a method for detecting the launch of an aircraft expendable instrument are provided. The aircraft expendable instrument launch system an aircraft expendable instrument, a launch tube, a magnetic field generator positioned in the launch tube, a magnetic field detector positioned in the aircraft expendable instrument, and an electronics electrically coupled to the magnetic field detector. The electronics operable to detect a signal provided by the magnetic field detector when the aircraft expendable instrument an air travels through a magnetic field generated by the magnetic field generator.

Abstract: Compounds of formula I and their metabolites are potent mediators of an inflammatory response: where a, b, c, d, e, f, V, W, X, Y, Ra, Ra?, Rb, Rb?, Rc, and Rc? are defined herein. In particular, the compounds of the invention are candidate therapeutics for treating inflammatory conditions.